medavail inc. is the developer of the medcenter automated dispensing and medication management technologies. the company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to atms. intended for deployment in hospitals, pharmacies, medical clinics, and other locations. the company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a prescription medication dispensing system.
Company profile
Ticker
MDVL
Exchange
Website
CEO
Joseph Mannello
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Atlas Therapeutics Corp, Marvin's Place, Inc., MYOS Corp, MYOS RENS TECHNOLOGY INC., Rough Tide Marine Operations, Inc.
SEC CIK
Corporate docs
IRS number
208758875
MDVL stock data
Latest filings (excl ownership)
8-K
MedAvail Receives Nasdaq Notification of Non-Compliance Related
17 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Other Events
14 Nov 23
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
18 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
MedAvail Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
MedAvail Announces 1-for-50 Reverse Stock Split
31 Jul 23
EFFECT
Notice of effectiveness
20 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
S-3/A
Shelf registration (amended)
14 Jul 23
Transcripts
MDVL
Earnings call transcript
2023 Q1
18 May 23
MDVL
Earnings call transcript
2022 Q4
13 Apr 23
MDVL
Earnings call transcript
2022 Q3
14 Nov 22
MDVL
Earnings call transcript
2022 Q2
12 Aug 22
MDVL
Earnings call transcript
2022 Q1
13 May 22
MDVL
Earnings call transcript
2021 Q4
25 Mar 22
MDVL
Earnings call transcript
2021 Q3
9 Nov 21
MDVL
Earnings call transcript
2021 Q2
12 Aug 21
MDVL
Earnings call transcript
2021 Q1
13 May 21
MDVL
Earnings call transcript
2020 Q1
11 May 20
Latest ownership filings
4
Ramona Seabaugh
2 Oct 23
4
Mark Edward Doerr
21 Aug 23
4
Ramona Seabaugh
21 Aug 23
4
Jeremy Green
21 Jun 23
SC 13D/A
Redmile Group, LLC
21 Jun 23
SC 13D/A
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
21 Jun 23
4
Fan Yu
21 Jun 23
4
Michael R Kramer
20 Jun 23
4
LAURIE MCGRAW
20 Jun 23
4
Glen D. Stettin
20 Jun 23
Financial summary
| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm |
| Cash burn (monthly) | 1.48 mm | 1.24 mm | 1.83 mm | 3.41 mm | 1.46 mm | 2.63 mm |
| Cash used (since last report) | 7.87 mm | 6.58 mm | 9.75 mm | 18.15 mm | 7.77 mm | 13.98 mm |
| Cash remaining | 7.17 mm | 8.45 mm | 5.29 mm | -3.11 mm | 7.27 mm | 1.05 mm |
| Runway (months of cash) | 4.8 | 6.8 | 2.9 | -0.9 | 5.0 | 0.4 |
Institutional ownership, Q2 2023
| 13F holders | Current |
|---|---|
| Total holders | 28 |
| Opened positions | 3 |
| Closed positions | 2 |
| Increased positions | 3 |
| Reduced positions | 4 |
| 13F shares | Current |
|---|---|
| Total value | 15.95 bn |
| Total shares | 101.72 mm |
| Total puts | 0.00 |
| Total calls | 3.11 mm |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Redmile | 34.60 mm | $8.48 bn |
| Ally Bridge Group-WTT Global Life Science Capital Partners | 34.24 mm | $9.97 mm |
| ABG-WTT Global Life Science Capital Partners GP | 15.03 mm | $3.68 bn |
| Alyeska Investment | 6.02 mm | $1.47 bn |
| Ally Bridge | 5.89 mm | $1.44 bn |
| Cigna Investments | 2.39 mm | $586.00 k |
| Vanguard | 1.06 mm | $259.43 mm |
| Adage Capital Partners GP, L.L.C. | 1.00 mm | $245.10 mm |
| Deerfield Management | 836.63 k | $205.06 mm |
| Geode Capital Management | 183.91 k | $45.08 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Sep 23 | Ramona Seabaugh | Common Stock | Sell | Dispose S | No | Yes | 5.6971 | 303 | 1.73 k | 1,222 |
| 1 Sep 23 | Ramona Seabaugh | Common Stock | Option exercise | Acquire M | No | No | 0 | 680 | 0.00 | 1,525 |
| 1 Sep 23 | Ramona Seabaugh | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 680 | 0.00 | 679 |
| 18 Aug 23 | Ramona Seabaugh | RSU Common Stock | Grant | Acquire A | No | No | 0 | 57,484 | 0.00 | 57,484 |
| 18 Aug 23 | Ramona Seabaugh | Stock Options Common Stock | Grant | Acquire A | No | No | 8.3 | 57,484 | 477.12 k | 57,484 |
| 18 Aug 23 | Mark Edward Doerr | RSU Common Stock | Grant | Acquire A | No | No | 0 | 125,000 | 0.00 | 125,000 |
| 18 Aug 23 | Mark Edward Doerr | Stock Options Common Stock | Grant | Acquire A | No | No | 8.3 | 125,000 | 1.04 mm | 125,000 |
| 16 Jun 23 | ABG WTT-MedAvail | Series A Warrant Common Stock | Other | Acquire J | Yes | No | 0.3854 | 965,130 | 371.96 k | 965,130 |
| 16 Jun 23 | ABG WTT-MedAvail | Series A Warrant Common Stock | Other | Acquire J | Yes | No | 0.3854 | 6,818,181 | 2.63 mm | 6,818,181 |
| 16 Jun 23 | Redmile | Series A Warrants to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.3854 | 38,916,562 | 15.00 mm | 38,916,562 |